KMT2E and acute promyelocytic leukemia: Principle component analysis using the transcriptome of APL patients (included in the TCGA cohort) demonstrated distinguished gene expression signature between the two groups (high MLL5 expression vs Low MLL5 expression) (Fig. 1B).